NICE (UK) plans to support new device for diagnosing liver damage without surgery
Cinnamon Girl said
Jan 19, 2015
NICE is consulting on draft guidance on a device that aims to diagnose and monitor liver damage, without the need for surgery. The provisional recommendations support using the device, Virtual Touch Quantification (VTq), in adults and children with chronic hepatitis B or C who need assessment of liver fibrosis.
The standard methods of assessing whether there is damage in the liver are ultrasound scans, transient elastography (e.g.Fibroscan), and biopsy. The draft guidance advises that VTq is as accurate as transient elastography in diagnosing and staging liver fibrosis, and may offer additional benefits in terms of allowing liver imaging as well as sampling selected areas. Using VTq may also create greater savings for hospitals where liver biopsy is the primary method for diagnosing and monitoring liver fibrosis.
NICE is consulting on draft guidance on a device that aims to diagnose and monitor liver damage, without the need for surgery. The provisional recommendations support using the device, Virtual Touch Quantification (VTq), in adults and children with chronic hepatitis B or C who need assessment of liver fibrosis.
The standard methods of assessing whether there is damage in the liver are ultrasound scans, transient elastography (e.g.Fibroscan), and biopsy. The draft guidance advises that VTq is as accurate as transient elastography in diagnosing and staging liver fibrosis, and may offer additional benefits in terms of allowing liver imaging as well as sampling selected areas. Using VTq may also create greater savings for hospitals where liver biopsy is the primary method for diagnosing and monitoring liver fibrosis.
Full article...
https://www.nice.org.uk/news/press-and-media/nice-plans-to-support-device-for-diagnosing-liver-damage-without-surgery